Nancy Lee

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

Nancy Lee, Chelsey Woodrum, Ali Nobil, 2009, BMC pharmacology.

Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model

Nancy Lee, A. Rauktys, S. Dabora, 2008, BMC dermatology.

Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis

A. Sagalowsky, S. Ashwal, S. Camposano, 2013, PloS one.

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease

J. Manola, F. Fennessy, A. Sagalowsky, 2011, PloS one.

Evaluation of hereditary risk in a mammography population.

Barbara L. Smith, D. Kopans, M. Gadd, 2005, Clinical breast cancer.

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

Adriaan P IJzerman, Kenneth A Jacobson, Kai Ye, 2009, BMC pharmacology.